Research reveals COVID-19’s lasting impact on brain function and structure

Study investigates post-COVID-19 cognitive defects, finding that SARS-CoV-2 infections are linked to brain injury markers and reduced cingulate cortex volume, with corticosteroids offering some cognitive protection.

Amid layoffs and a hit to earnings, Bristol’s new CEO shares his vision for the future

Christopher Boerner, 53, took over as the chief executive officer of Bristol Myers Squibb last November, and immediately made a big move: a series of

April 25, 2024

Quicktake – Purple Biotech (PPBT) | Biotech Investment Blog | biotickr

Purple Biotech Ltd., a clinical-stage company, is developing treatments for cancers to overcome drug resistance. The lead oncology asset CM24 is a monoclonal antibody that

June 9, 2023

Medacta NextAR Rod Optimizer, a Disruptive Technology Redefining Rod Management in Spine Surgery, wins the 2024 Spine Technology Award from Orthopedics This Week – Biotech Investments

Medacta Group SA / Key word(s): Miscellaneous Medacta NextAR Rod Optimizer, a Disruptive Technology Redefining Rod Management in Spine Surgery, wins the 2024 Spine Technology

September 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.